Russell Alan J 4
4 · Edgewise Therapeutics, Inc. · Filed Nov 13, 2025
Insider Transaction Report
Form 4
Russell Alan J
DirectorChief Scientific Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2025-11-12−100,000→ 1,147,365 totalExercise: $0.18From: 2021-06-27Exp: 2032-06-27→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2025-11-12$0.18/sh+100,000$18,000→ 123,400 total - Sale
Common Stock
2025-11-12$21.12/sh−100,000$2,112,450→ 23,400 total
Footnotes (1)
- [F1]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $21.35, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.